Period,symbol,NAV,sharesOutstanding,researchDevelopment,effectOfAccountingCharges,incomeBeforeTax,minorityInterest,netIncome,sellingGeneralAdministrative,grossProfit,ebit,operatingIncome,otherOperatingExpenses,interestExpense,extraordinaryItems,nonRecurring,otherItems,incomeTaxExpense,totalRevenue,totalOperatingExpenses,costOfRevenue,totalOtherIncomeExpenseNet,discontinuedOperations,netIncomeFromContinuingOps,netIncomeApplicableToCommonShares,intangibleAssets,capitalSurplus,totalLiab,totalStockholderEquity,otherCurrentLiab,totalAssets,commonStock,otherCurrentAssets,retainedEarnings,otherLiab,goodWill,treasuryStock,otherAssets,cash,totalCurrentLiabilities,deferredLongTermAssetCharges,shortLongTermDebt,otherStockholderEquity,propertyPlantEquipment,totalCurrentAssets,longTermInvestments,netReceivables,longTermDebt,inventory,accountsPayable,changeToLiabilities,totalCashflowsFromInvestingActivities,totalCashFromFinancingActivities,changeToOperatingActivities,changeInCash,repurchaseOfStock,effectOfExchangeRate,totalCashFromOperatingActivities,depreciation,otherCashflowsFromInvestingActivities,dividendsPaid,changeToInventory,changeToAccountReceivables,otherCashflowsFromFinancingActivities,changeToNetincome,capitalExpenditures,netBorrowings,issuanceOfStock,WC,language,region,quoteType,triggerable,quoteSourceName,marketState,currency,exchange,shortName,market,priceHint,fullExchangeName,longName,financialCurrency,averageDailyVolume3Month,averageDailyVolume10Day,fiftyTwoWeekLowChange,fiftyTwoWeekLowChangePercent,fiftyTwoWeekRange,fiftyTwoWeekHighChange,fiftyTwoWeekHighChangePercent,fiftyTwoWeekLow,fiftyTwoWeekHigh,earningsTimestamp,earningsTimestampStart,earningsTimestampEnd,trailingAnnualDividendRate,trailingPE,trailingAnnualDividendYield,epsTrailingTwelveMonths,exchangeDataDelayedBy,bookValue,fiftyDayAverage,fiftyDayAverageChange,fiftyDayAverageChangePercent,twoHundredDayAverage,twoHundredDayAverageChange,twoHundredDayAverageChangePercent,marketCap,priceToBook,sourceInterval,exchangeTimezoneName,exchangeTimezoneShortName,gmtOffSetMilliseconds,esgPopulated,tradeable,regularMarketChangePercent,regularMarketDayRange,regularMarketPreviousClose,bid,ask,messageBoardId,regularMarketPrice,regularMarketTime,regularMarketChange,regularMarketOpen,regularMarketDayHigh,regularMarketDayLow,regularMarketVolume,Beta (5Y Monthly),52-Week Change 3,S&P500 52-Week Change 3,52 Week High 3,52 Week Low 3,50-Day Moving Average 3,200-Day Moving Average 3,Avg Vol (3 month) 3,Avg Vol (10 day) 3,Shares Outstanding 5,Implied Shares Outstanding 6,Float,% Held by Insiders 1,% Held by Institutions 1,Shares Short 4,Short Ratio 4,Short % of Float 4,Short % of Shares Outstanding 4,Shares Short (prior month ) 4,Forward Annual Dividend Rate 4,Forward Annual Dividend Yield 4,Trailing Annual Dividend Rate 3,Trailing Annual Dividend Yield 3,5 Year Average Dividend Yield 4,Payout Ratio 4,Dividend Date 3,Ex-Dividend Date 4,Last Split Factor 2,Last Split Date 3,Fiscal Year Ends,Most Recent Quarter (mrq),Profit Margin,Operating Margin (ttm),Return on Assets (ttm),Return on Equity (ttm),Revenue (ttm),Revenue Per Share (ttm),Quarterly Revenue Growth (yoy),Gross Profit (ttm),EBITDA,Net Income Avi to Common (ttm),Diluted EPS (ttm),Quarterly Earnings Growth (yoy),Total Cash (mrq),Total Cash Per Share (mrq),Total Debt (mrq),Total Debt/Equity (mrq),Current Ratio (mrq),Book Value Per Share (mrq),Operating Cash Flow (ttm),Levered Free Cash Flow (ttm),index,zip,sector,fullTimeEmployees,compensationRisk,auditRisk,longBusinessSummary,city,phone,state,shareHolderRightsRisk,compensationAsOfEpochDate,governanceEpochDate,boardRisk,country,website,maxAge,overallRisk,address1,industry
t0,ZOE.DE,-8000000,474767008,120000000,,636000000,2000000,512000000,495000000,1382000000,726000000,726000000,,-57000000,,,,125000000,1948000000,1222000000,566000000,-90000000,,511000000,512000000,1640000000,1044000000,9717000000,4350000000,243000000,14069000000,5000000,402000000,6492000000,883000000,2718000000,-3191000000,169000000,3658000000,2091000000,103000000,600000000,-623000000,2463000000,7048000000,31000000,1170000000,6596000000,1802000000,369000000,21000000.0,-139000000.0,-290000000.0,-38000000.0,56000000.0,-166000000.0,4000000.0,481000000.0,112000000.0,-15000000.0,-119000000.0,-122000000.0,-41000000.0,-5000000.0,37000000.0,-113000000.0,,,4957000000,en-US,US,EQUITY,False,Delayed Quote,REGULAR,EUR,GER,"ZOETIS INC. CL.A  DL -,01",de_market,2,XETRA,Zoetis Inc.,USD,51,8,50.68,0.4143231,122.32 - 178.55,-5.550003,-0.031083746,122.32,178.55,1620304200,1635942600,1636374600,0.85,55.662804,0.004913295,3.108,0,8.609,171.61714,1.3828583,0.008057809,148.96669,24.03331,0.16133346,82134695936,20.09525,15,Europe/Berlin,CEST,7200000,False,False,0.0,171.8 - 173.0,173.0,172.0,176.45,finmb_215548781,173.0,1630510546,0.0,171.8,173.0,171.8,10,0.64,,,178.55,122.32,171.62,148.97,51,8,474.77M,,473.13M,0.20%,92.66%,,,,,,0.85,0.48%,0.85,0.49%,,22.56%,,"Jul 20, 2021",,,"Dec 31, 2020","Jun 30, 2021",25.76%,36.21%,12.36%,51.94%,7.41B,15.59,25.80%,4.64B,3.08B,1.91B,3.11,35.80%,3.67B,7.75,7.35B,168.82,3.37,8.61,2.16B,1.3B,Value,07054,Healthcare,11300,6,4,"Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. The company offers vaccines, which are biological preparations to prevent diseases of the respiratory, gastrointestinal, and reproductive tracts or induce a specific immune response; anti-infectives that prevent, kill, or slow the growth of bacteria, fungi, or protozoa; and parasiticides that prevent or eliminate external and internal parasites that include fleas, ticks, and worms. It also provides other pharmaceutical products, which comprise pain and sedation, antiemetic, reproductive, and oncology products; dermatology products for itch associated with allergic conditions and atopic dermatitis; and medicated feed additives that offer medicines to livestock. In addition, the company offers portable blood and urine analysis systems, and point-of-care diagnostic products, including instruments and reagents, rapid immunoassay tests, reference laboratory kits, blood glucose monitors, and laboratory services; and other non-pharmaceutical products, including nutritionals and agribusiness services, as well as products and services in areas, such as biodevices, genetics tests, and precision livestock farming. It markets its products to veterinarians, livestock producers, and retail outlets, as well as third-party veterinary distributors through its sales representatives, and technical and veterinary operations specialists. The company was founded in 1952 and is headquartered in Parsippany, New Jersey.",Parsippany,973 822 7000,NJ,9,1609372800,1625097600,1,United States,http://www.zoetis.com,86400,6,10 Sylvan Way,Drug Manufacturers—Specialty & Generic
t-1,ZOE.DE,-289000000,474767008,118000000,,687000000,3000000,559000000,409000000,1323000000,756000000,756000000,,-57000000,,,,129000000,1871000000,1115000000,548000000,-69000000,,558000000,559000000,1671000000,1030000000,9704000000,4089000000,306000000,13796000000,5000000,347000000,6099000000,892000000,2707000000,-3045000000,157000000,3602000000,2066000000,100000000,603000000,-633000000,2416000000,6794000000,51000000,1125000000,6587000000,1700000000,346000000,-112000000.0,-63000000.0,-339000000.0,20000000.0,-2000000.0,-220000000.0,4000000.0,400000000.0,109000000.0,17000000.0,-119000000.0,-84000000.0,-108000000.0,-5000000.0,16000000.0,-77000000.0,,,4728000000,en-US,US,EQUITY,False,Delayed Quote,REGULAR,EUR,GER,"ZOETIS INC. CL.A  DL -,01",de_market,2,XETRA,Zoetis Inc.,USD,51,8,50.68,0.4143231,122.32 - 178.55,-5.550003,-0.031083746,122.32,178.55,1620304200,1635942600,1636374600,0.85,55.662804,0.004913295,3.108,0,8.609,171.61714,1.3828583,0.008057809,148.96669,24.03331,0.16133346,82134695936,20.09525,15,Europe/Berlin,CEST,7200000,False,False,0.0,171.8 - 173.0,173.0,172.0,176.45,finmb_215548781,173.0,1630510546,0.0,171.8,173.0,171.8,10,0.64,,,178.55,122.32,171.62,148.97,51,8,474.77M,,473.13M,0.20%,92.66%,,,,,,0.85,0.48%,0.85,0.49%,,22.56%,,"Jul 20, 2021",,,"Dec 31, 2020","Jun 30, 2021",25.76%,36.21%,12.36%,51.94%,7.41B,15.59,25.80%,4.64B,3.08B,1.91B,3.11,35.80%,3.67B,7.75,7.35B,168.82,3.37,8.61,2.16B,1.3B,Value,07054,Healthcare,11300,6,4,"Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. The company offers vaccines, which are biological preparations to prevent diseases of the respiratory, gastrointestinal, and reproductive tracts or induce a specific immune response; anti-infectives that prevent, kill, or slow the growth of bacteria, fungi, or protozoa; and parasiticides that prevent or eliminate external and internal parasites that include fleas, ticks, and worms. It also provides other pharmaceutical products, which comprise pain and sedation, antiemetic, reproductive, and oncology products; dermatology products for itch associated with allergic conditions and atopic dermatitis; and medicated feed additives that offer medicines to livestock. In addition, the company offers portable blood and urine analysis systems, and point-of-care diagnostic products, including instruments and reagents, rapid immunoassay tests, reference laboratory kits, blood glucose monitors, and laboratory services; and other non-pharmaceutical products, including nutritionals and agribusiness services, as well as products and services in areas, such as biodevices, genetics tests, and precision livestock farming. It markets its products to veterinarians, livestock producers, and retail outlets, as well as third-party veterinary distributors through its sales representatives, and technical and veterinary operations specialists. The company was founded in 1952 and is headquartered in Parsippany, New Jersey.",Parsippany,973 822 7000,NJ,9,1609372800,1625097600,1,United States,http://www.zoetis.com,86400,6,10 Sylvan Way,Drug Manufacturers—Specialty & Generic
t-2,ZOE.DE,-635000000,474767008,133000000,,420000000,4000000,359000000,518000000,1221000000,530000000,530000000,,-58000000,,,,62000000,1807000000,1277000000,586000000,-110000000,,358000000,359000000,1710000000,1065000000,9836000000,3769000000,203000000,13609000000,5000000,364000000,5659000000,891000000,2694000000,-2960000000,178000000,3604000000,2170000000,94000000,621000000,-730000000,2394000000,6611000000,22000000,1013000000,6612000000,1628000000,457000000,98000000.0,-177000000.0,-597000000.0,126000000.0,-50000000.0,-3000000.0,6000000.0,718000000.0,63000000.0,-20000000.0,-95000000.0,-52000000.0,5000000.0,-2000000.0,73000000.0,-152000000.0,-497000000.0,,4441000000,en-US,US,EQUITY,False,Delayed Quote,REGULAR,EUR,GER,"ZOETIS INC. CL.A  DL -,01",de_market,2,XETRA,Zoetis Inc.,USD,51,8,50.68,0.4143231,122.32 - 178.55,-5.550003,-0.031083746,122.32,178.55,1620304200,1635942600,1636374600,0.85,55.662804,0.004913295,3.108,0,8.609,171.61714,1.3828583,0.008057809,148.96669,24.03331,0.16133346,82134695936,20.09525,15,Europe/Berlin,CEST,7200000,False,False,0.0,171.8 - 173.0,173.0,172.0,176.45,finmb_215548781,173.0,1630510546,0.0,171.8,173.0,171.8,10,0.64,,,178.55,122.32,171.62,148.97,51,8,474.77M,,473.13M,0.20%,92.66%,,,,,,0.85,0.48%,0.85,0.49%,,22.56%,,"Jul 20, 2021",,,"Dec 31, 2020","Jun 30, 2021",25.76%,36.21%,12.36%,51.94%,7.41B,15.59,25.80%,4.64B,3.08B,1.91B,3.11,35.80%,3.67B,7.75,7.35B,168.82,3.37,8.61,2.16B,1.3B,Value,07054,Healthcare,11300,6,4,"Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. The company offers vaccines, which are biological preparations to prevent diseases of the respiratory, gastrointestinal, and reproductive tracts or induce a specific immune response; anti-infectives that prevent, kill, or slow the growth of bacteria, fungi, or protozoa; and parasiticides that prevent or eliminate external and internal parasites that include fleas, ticks, and worms. It also provides other pharmaceutical products, which comprise pain and sedation, antiemetic, reproductive, and oncology products; dermatology products for itch associated with allergic conditions and atopic dermatitis; and medicated feed additives that offer medicines to livestock. In addition, the company offers portable blood and urine analysis systems, and point-of-care diagnostic products, including instruments and reagents, rapid immunoassay tests, reference laboratory kits, blood glucose monitors, and laboratory services; and other non-pharmaceutical products, including nutritionals and agribusiness services, as well as products and services in areas, such as biodevices, genetics tests, and precision livestock farming. It markets its products to veterinarians, livestock producers, and retail outlets, as well as third-party veterinary distributors through its sales representatives, and technical and veterinary operations specialists. The company was founded in 1952 and is headquartered in Parsippany, New Jersey.",Parsippany,973 822 7000,NJ,9,1609372800,1625097600,1,United States,http://www.zoetis.com,86400,6,10 Sylvan Way,Drug Manufacturers—Specialty & Generic
t-3,ZOE.DE,-882000000,474767008,112000000,,597000000,5000000,479000000,419000000,1241000000,670000000,670000000,,-62000000,,,,118000000,1786000000,1116000000,545000000,-73000000,,479000000,479000000,1794000000,1040000000,10118000000,3602000000,210000000,13725000000,5000000,457000000,5526000000,928000000,2690000000,-2969000000,161000000,3654000000,2400000000,97000000,1111000000,-735000000,2293000000,6757000000,30000000,1012000000,6623000000,1626000000,357000000,12000000.0,-174000000.0,-93000000.0,-23000000.0,301000000.0,-3000000.0,6000000.0,562000000.0,111000000.0,-25000000.0,-95000000.0,-61000000.0,-2000000.0,-2000000.0,46000000.0,-117000000.0,-497000000.0,2000000.0,4357000000,en-US,US,EQUITY,False,Delayed Quote,REGULAR,EUR,GER,"ZOETIS INC. CL.A  DL -,01",de_market,2,XETRA,Zoetis Inc.,USD,51,8,50.68,0.4143231,122.32 - 178.55,-5.550003,-0.031083746,122.32,178.55,1620304200,1635942600,1636374600,0.85,55.662804,0.004913295,3.108,0,8.609,171.61714,1.3828583,0.008057809,148.96669,24.03331,0.16133346,82134695936,20.09525,15,Europe/Berlin,CEST,7200000,False,False,0.0,171.8 - 173.0,173.0,172.0,176.45,finmb_215548781,173.0,1630510546,0.0,171.8,173.0,171.8,10,0.64,,,178.55,122.32,171.62,148.97,51,8,474.77M,,473.13M,0.20%,92.66%,,,,,,0.85,0.48%,0.85,0.49%,,22.56%,,"Jul 20, 2021",,,"Dec 31, 2020","Jun 30, 2021",25.76%,36.21%,12.36%,51.94%,7.41B,15.59,25.80%,4.64B,3.08B,1.91B,3.11,35.80%,3.67B,7.75,7.35B,168.82,3.37,8.61,2.16B,1.3B,Value,07054,Healthcare,11300,6,4,"Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. The company offers vaccines, which are biological preparations to prevent diseases of the respiratory, gastrointestinal, and reproductive tracts or induce a specific immune response; anti-infectives that prevent, kill, or slow the growth of bacteria, fungi, or protozoa; and parasiticides that prevent or eliminate external and internal parasites that include fleas, ticks, and worms. It also provides other pharmaceutical products, which comprise pain and sedation, antiemetic, reproductive, and oncology products; dermatology products for itch associated with allergic conditions and atopic dermatitis; and medicated feed additives that offer medicines to livestock. In addition, the company offers portable blood and urine analysis systems, and point-of-care diagnostic products, including instruments and reagents, rapid immunoassay tests, reference laboratory kits, blood glucose monitors, and laboratory services; and other non-pharmaceutical products, including nutritionals and agribusiness services, as well as products and services in areas, such as biodevices, genetics tests, and precision livestock farming. It markets its products to veterinarians, livestock producers, and retail outlets, as well as third-party veterinary distributors through its sales representatives, and technical and veterinary operations specialists. The company was founded in 1952 and is headquartered in Parsippany, New Jersey.",Parsippany,973 822 7000,NJ,9,1609372800,1625097600,1,United States,http://www.zoetis.com,86400,6,10 Sylvan Way,Drug Manufacturers—Specialty & Generic
